Created by the World Health Organization (WHO), Gavi, and the Coalition for Epidemic Preparedness Innovations (CEPI), the COVID-19 Vaccines Global Access (COVAX) works to improve the equity of COVID-19 vaccine access globally. However, this initiative has not been as successful as initially envisioned, with less than 10 percent of the population in low-income countries currently being vaccinated against COVID-19. Meanwhile, more than 80 percent of the population in high-income nations have been vaccinated. Despite low vaccination rates in low-income countries, a recent study published by WHO found that COVAX has helped reduce global inequities in vaccine distribution. However, vaccine hoarding and delays in the fulfillment of funds pledged by wealthier nations to the COVAX program has ultimately hindered the success of COVAX program. Learn more about COVAX, here.
Last Updated on July 24, 2022 by Aimed Alliance
